Nike’s unexpected CFO change has heightened concerns about the sportswear giant’s turnaround efforts, according to Evercore ISI analysts, increasing the likelihood that earnings forecasts will be revised ahead of its much-anticipated investor day later this year.
On Wednesday, Nike appointed former Pfizer CFO David Denton as its new executive vice president and chief financial officer, effective August 17. He will replace Matt Friend, who will remain with the company until September 4.
While Evercore described Denton as a highly capable financial executive, the brokerage noted that the timing of the CFO transition raises fresh questions about Nike’s outlook amid slowing sales, distribution channel disruptions, and challenges with its product lineup.
Earlier that same day, Evercore downgraded Nike from “Outperform” to “Neutral,” citing deteriorating results from its sales channel monitoring, weak momentum in lifestyle and family retail segments, disappointing launches of retro Jordan models, and supply chain issues in Europe affecting deliveries of World Cup-related merchandise. According to Evercore, investors are already closely watching Nike’s previously stated forecast of a low single-digit decline in revenue for the first half of fiscal 2027. The firm warned that even a minor deviation from this projection could pressure the stock.
The brokerage also questioned whether the CFO change could complicate preparations for the expected fall analyst day, which CEO Elliott Hill recently indicated would take place in November.
Evercore believes that a CFO taking the reins in mid-August would face an extremely challenging task in gaining enough insight into the company’s operations to present a multi-year strategic plan just a few months later.
As a result, analysts stated that the probability of a significant downward revision to earnings expectations before the investor event has increased, suggesting that management may need to lower guidance in advance to avoid disappointing investors during the analyst day itself.
Evercore emphasized that Nike’s problems appear to be worsening rather than stabilizing, making it increasingly difficult to justify the company’s historical valuation premium—despite the fact that its shares are trading near a 15-year low in terms of enterprise value to revenue.
Nike’s stock closed Tuesday’s trading session down 1.9% at $42.38. In after-hours trading, shares edged up 0.8% to $42.73 following the announcement of the CFO change.
About the Author
